(5-BROMOPYRIDIN-3-YL)-MORPHOLIN-4-YL-METHANONE, 97.0%, 1g

(4-Acetamidophenyl)(fluorosulfonyl)sulfamoyl fluoride, 97%, 5g

4,4'-(Propane-2,2-diyl)bis(2-methylphenol), 95.0%, 250g

3-Hydroxypropionic acid, 30% in water, 95.0%, 5g

Ethyl 5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxylate, 97.0%, 1g

Romifidine, >95.0%(HPLC), 10mg

1-[(4-Bromo-3-chlorophenyl)methyl]-pyrrolidine, 95+%, 500mg

2,5-Dioxopyrrolidin-1-yl-S-benzyl-N-(tert-butoxycarbonyl)-D-cysteinate, 98+%, 5g

BOC-(2S,3S)-3-Hydroxypyrrolidine-2-carboxylic acid methyl ester, 95.0%, 1g

4-Methyl-2-(2-methyl-1-propenyl)tetrahydropyran (cis- and trans- mixture)>97.0%(GC)25g

2-(Methylthio)benzimidazole>99.0%(HPLC)(T)25g

ROTI®Plate90 XLD

Methyl 2,6-difluoro-3-hydroxybenzoate, 95.0%, 50mg